Robert Perneczky
Robert Perneczky is a prominent dementia researcher at the Alzheimer Research Center of Ludwig Maximilians University in Munich. He has been at the forefront of studying the effects of new antibody therapies on Alzheimer’s disease, emphasizing that these treatments may be most effective when administered early in the disease's progression. His insights contribute significantly to the understanding of how to combat cognitive decline associated with dementia.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 1 | 6.00 | 0.09% | +0% | 8,654,622 | 7,991 | $700,000 | 646$ |
| Totals | 1 | 8,654,622 | 7,991 | $700,000 | 646$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Robert Perneczky leads a specialized department for mental illnesses in the elderly at the University Hospital of Munich.
6
Switzerland:
Robert Perneczky is from the Alzheimer Research Center at Ludwig Maximilians University Munich.
5
Switzerland:
Robert Perneczky from the Alzheimer Research Center at Ludwig Maximilians University in Munich discusses the effectiveness of antibodies in treating Alzheimer's disease.
5